A complete clinical data management platform for early stage drug and device projects

Focus on science.  Stop guessing clinical outcomes.

Flaskdata.io is a data-driven platform for early stage drug and device clinical trials.

Flaskdata.io provides you with a same day picture of missing outcome data and adverse event trends. You execute innovative projects now. You take risk-decisions now, not 6 weeks from now.

We believe that if you develop cutting-edge therapeutics, you deserve cutting-edge data management technology at a fair price.

We work with big, publicly-traded companies and 3 man medical device startups.  Thousands of patients around the world use the Flaskdata.io clinical data platform in the US, Israel, India and Brazil.

Flaskdata creates a single source of truth from API calls, mobile, cloud, wearables, medical IoT, patient ePRO and EDC from research sites.  You can start small with a mobile ePRO solution for 10 patients and grow all the way to Phase 3, FDA approval and Post-marketing.

Flaskdata.io Collect, Detect and act on your clinical data
Collect, Detect & Act

We will stand by you in good and bad times with fanatic service, straight-talk and the highest professional and ethical standards.

A secure cloud platform for your clinical data

Flaskdata was designed for security and privacy and complies with  HIPAA, CCPA, GDPR, 21 CFR Part 11 and Israeli Privacy Regulations.

Let’s talk

We specialize in early stage drug and device projects

Early stage drug and device projects are often challenged by tight budgets and an inadequate Phase 1 protocol design. We’ll provide you with robust digital data management tools that will enable you to work with a small head-count without compromising tight adherence to protocol requirements and careful monitoring of patient safety.

Our customer support and software engineering teams love to work with startups on tight budgets and challenging delivery schedules.

We provide creative, agile solutions for biopharma, connected drugs, connected medical devices, digital therapeutics and AI-driven medical applications that need to be validated for FDA approval.  We love challenges.

Let’s talk

Automate data quality and safety monitoring

Flaskdata enables you to collect data from your sites, patients and connected devices. You can define data quality and safety monitoring metrics on your patient timelines from any of the data you collect.  The unified database will provide you a precise and immediate picture of missing outcome data and adverse event trends with with real-time alerts to patients, clinops teams and project managers.

Let’s talk


The Flaskdata subscription: Zero-admin. Unlimited studies, sites, users and data.

    1. CTMS to manage your study portfolio
    2. DDC – Direct data collection
    3. 21 CFR compliant EDC
    4. Self-service Visual Forms designer
    5. ePRO – Desktop and native Android mobile
    6. Data quality and patient safety metrics
    7. Alerts
    8. Analytics
    9. Report tools
    10. External API integration
    11. Connected device support
    12. Single sign-on with Google, SAML and OPENID standards.
    13. The entire platform exposed as a REST API

All this for $50/month/patient in an annual subscription.

Sign up for a free account. Develop now. Pay when you go live.


Human conditions

Women's health

Flaskdata.io native mobile ePRO is an accessible and easy-to-use multi-lingual interface for women who participate in your clinical trials. Flaskdata.io automated monitoring provides extremely fast detection of protocol deviations and adverse events and has proven to be a key success factor in ensuring high data quality and patient safety in gynecology studies. The combination of native mobile data collection, passive sensors and real-time detection and response enables your clinical operations teams to perform studies on-time and on budget while providing a minimalistic, low-touch user interface for the women in your study.


Flaskdata.io customers are successfully executing global multi-center studies in NASH, chronic constipation, AI-driven endoscopy and pre and post-marketing studies of diagnostic devices for Calprotectin, H. pylori, Campylobacter, Rotavirus and E. coli.

A pivotal study for chronic constipation put the unified database to good use by automatically integrating data from connected drugs, native mobile ePRO (in Russian, English, Arabic and Hebrew) and the sponsor EDC system.

Using a small number of heuristic rules the Flaskdata.io system measures protocol compliance in real-time integrating data streams from patients, sites and drug delivery.

High productivity
Flaskdata.io automation supported a 3-person clinops team in their mission of managing over 100 research sites.


Theranica develops advanced, clinically proven, safe and affordable digital therapeutics, addressing some of the world’s most prevalent neurological pain diseases. We harness a pain inhibition mechanism known as Conditioned Pain Modulation (CPM). This is the notion that in certain diseases, including migraine, patients have dysfunctional pain processing; a harmless stimulus is perceived by the brain as noxious and the patients experience pain. CPM may be triggered by delivering a remote non-painful but well-felt peripheral stimulus. Once triggered, CPM results with increased release of certain neurotransmitters in the brain stem that are capable of shutting down the pain.. Flaskdata provided Theranica with an integrated continuous clinical data collection and automated monitoring platform.   The continuous data feed ingests data from the EDC, the Nerivio wearable device and patient outcomes via the Theranica mobile app that connects with Flask API.


Flaskdata is at the forefront of providing support for clinical R&D of innovative neuroscience therapies.  The global Flaskdata.io multi-center clinical trial platform serves companies developing therapeutics for treating depression, OCD and bipolar disorders. The data-driven solution for neuroscience uses the Flask API to integrate clinical data with customer deep learning algorithms in order to improve diagnosis, monitoring and treatment of brain-related disorders.

Assure adherence in challenging mental health scenarios

Flaskdata.io helps the neuroscience study team assure patient adherence by providing automated data and safety monitoring tools. Flaskdata.io Detect and Act algorithms automatically detect dosing anomalies by observing dosing titration trends over time. 

Alerts are pushed to the site clinops teams and to sponsor project management in order to provide a same-day response to protocol variations.


Lung cancer remains a leading cause of death from cancer globally, due to its high incidence and late-stage diagnosis. Most patients are currently diagnosed with late-stage cancer, though research has shown 5-year survival rates are up to 10 times greater when disease is detected early.

Flaskdata.io customer Nucleix has developed an ultra-sensitive liquid-biopsy technology for earlier detection of cancer.  Leveraging PCR-based epigenetics, the pioneering Nucleix testing approach uses methylation-based identification for early-stage and recurring cancer detection.

Data-driven solution for oncology

Flaskdata.io provided Nucleix with an EDC platform to perform large-scale data collection of patient medical histories and biomarkers. The data-driven solution for oncology uses the Flask API to integrate clinical data with customer machine learning algorithms in order to train optimal biomarker panels.

An ultra-sensitive, proprietary platform is capable of detecting a single cancer molecule in a background of 200,000 normal molecules.

This ultra-sensitivity enables the Nucleix EpiCheck to detect cancer at its earliest stages when treatment has the greatest impact for patients.

We're proud to have had the privilege to contribute from our know-how and technology to war on lung and bladder cancer.


Our values

We put our customers first. We care deeply about your success.
We’re a diverse and interdisciplinary team with people skills  and hard-core tech skills.
We put these skills to work for you.

Schedule a call

Read and follow us on Medium and on LinkedIn


Scroll to Top